Acta Neuropathologica

, Volume 80, Issue 3, pp 287–294 | Cite as

Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation

  • T. Morimura
  • C. Neuchrist
  • K. Kitz
  • H. Budka
  • O. Scheiner
  • D. Kraft
  • H. Lassmann
Regular Papers


Cryostat sections of 12 gliomas and of 3 peritumoral brain tissue samples were investigated for mononuclear cell infiltration by immunohistochemistry, concentrating on cells expressing monocyte/macrophage markers. Only low numbers of T cells were detected in the tumors, whereas in average 20%–30% of all cells present in the samples were recognized by various macrophage markers. These cells carried surface epitopes with known function, like Fc-γ (Fcg) and complement receptors. Microglial cells, in comparison to typical debris laden macrophages, were only recognized by a restricted panel of macrophages markers (anti-Fcg receptors 1, 2, 3, complement receptor CR3, HLA DR, common leucocyte antigen CD45 and the monocyte marker RM3/1). In peritumoral tissue mainly dendritic, microglia-like cells were present, which revealed decreased expression of antigens CD4, RM3/1 and Fcg receptors in comparison to those in gliomas. A significant positive correlation was found between the number of RM3/1 or CR3 (CD11b)-positive cells and the proliferation rate of the tumors as documented by the number of bromodeoxyuridine-positive or Ki-67+ cells.

Key words

Glioma Macrophages Microglia Fc-receptors Complement receptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Akiyama H, Itagaki S, McGeer PL (1988) Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions. J Neurosci Res 20:145–157Google Scholar
  2. 2.
    Bertrand I, Mannen H (1960) Etude des reactions vasculaires dans les astrocytomes. Rev Neurol (Paris) 102:3–19Google Scholar
  3. 3.
    Böker DK, Kalff R, Gullotta F, Weekes-Seifert S, Möhrer V (1984) Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. Clin Neuropathol 3:143–147Google Scholar
  4. 4.
    Brooks WH, Markesbery WR, Gupta GD, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224Google Scholar
  5. 5.
    Budka H, Majdic O, Knapp W (1985) Cross-reactivity between human hematopoetic cells and brain tumors as defined by monoclonal antibodies. J Neurooncol 3:173–179Google Scholar
  6. 6.
    Bullard DE, Bigner DD (1985) Application of monoclonal antibodies in the diagnosis and treatment of primary brain tumors. J Neurosurg 61:901–911Google Scholar
  7. 7.
    Carrel S, De Tribolet N, Gross N (1982) Expression of HLADR and common leucocyte antigens on glioma cells. Eur J Immunol 12:354–357Google Scholar
  8. 8.
    Coakham HB, Kemshead JT (1987) The present role of monoclonal antibodies in the diagnosis and therapy of brain tumors. Wien Klin Wochenschr 99:372–378Google Scholar
  9. 9.
    Di Lorenzo N, Palma L, Nicole S (1977) Lymphocytic infiltration in long-survival glioblastomas: possible host resistance. Acta Neurochir (Wien) 39:27–33Google Scholar
  10. 10.
    Epenetos AA, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender JP, McKenzie CG (1985) Antibody-guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 290:1463–1466Google Scholar
  11. 11.
    Esiri MM, McGee JD (1986) Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J Clin Pathol 39:615–621Google Scholar
  12. 12.
    Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E (1982) Production of prostaglandin E- and interleukin 1-like factors by cultured astrocytes and C6 glioma cells. J Immunol 129:2413–2419Google Scholar
  13. 13.
    Fontana A, Hengartner H, De Tribolet N, Weber E (1984) Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837–1844Google Scholar
  14. 14.
    Frei K, Bodmer S, Schwerdel C, Fontana A (1984) Astrocyte-derived interleukin 3 as a growth factor for microglia and peritoneal macrophages. J Immunol 137:3521–3527Google Scholar
  15. 15.
    Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17: 1271–1278Google Scholar
  16. 16.
    Graeber MB, Streit WJ, Kreutzberg GW (1988) Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglia cells. J Neurosci Res 21:18–24Google Scholar
  17. 17.
    Graziano RF, Fanger MW (1987) Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocytes cell surface. J Immunol 138:945–950Google Scholar
  18. 18.
    Hartung HP, Schäfer B, Heininger K, Toyka K (1986) Interference with arachidonic acid metabolism suppresses experimental allergic neuritis. Ann Neurol 20:168–168Google Scholar
  19. 19.
    Hartung HP, Schäfer B, Heininger K, Toyka K (1988) Suppression of experimental autoimmune neuritis by oxygen radical scavengers superoxide dismutase and catalase. Ann Neurol 23:453–460Google Scholar
  20. 20.
    Hitchcook ER, Morris CS (1988) Mononuclear cell infiltration in central portions of human astrocytomas. J Neurosurg 68:432–437Google Scholar
  21. 21.
    Hogg N, McDonald S, Slusarenko M, Beverley PCL (1984) Monoclonal antibodies specific for monocytes, granulocytes and endothelium. Immunology 53:753–767Google Scholar
  22. 22.
    Knapp W, Majdic O, Stockinger H, Bettelheim P, Lizska K, Köller U, Peschl C (1984) Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leucemia. Med Oncol Tumor Pharmacother 4:257–262Google Scholar
  23. 23.
    Kril MP, Apuzzo LJ (1983) Observations in the study of T lymphocyte subsets by monoclonal antibodies and flow cytometric analysis of intracranial neoplastic disorders. Clin Neurosurg 30:125–136Google Scholar
  24. 24.
    Looney RJ, Abraham GN, Anderson CL (1986) Human monocytes and U937 cells bear two distinct Fe receptors for IgG. J Immunol 136:1641–1647Google Scholar
  25. 25.
    McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76:550–557Google Scholar
  26. 26.
    Moranz RA, Wood GW, Foster M, Clark M, Gollahon K (1979) Macrophages in experimental and human brain tumors. J Neurosurg 50:305–311Google Scholar
  27. 27.
    Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labelling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol 77:276–282Google Scholar
  28. 28.
    Mork SJ, Nyland H, Matre R, Ganz J (1985) Characterization of host mononuclear cells in gliomas. (abstract) J Neuropathol Exp Neurol 44:317Google Scholar
  29. 29.
    Paine JT, Handa H, Yamasaki T, Yamashita J, Miyatake S (1986) Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. Neurosurgery 18:776–772Google Scholar
  30. 30.
    Palma L, Di Lorenzo N, Guidetti B (1978) Lymphocytic infiltration in primary glioblastomas and recidivous gliomas: incidence, fate and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861Google Scholar
  31. 31.
    Perlmann H, Perlmann P, Schreiber RD, Müller-Eberhard HJ (1981) Interaction of target cell bound C3b and C3d with human lymphocyte receptors — Enhancement of antibody dependent cellular cytotoxicity. J Exp Med 153:1592–1602Google Scholar
  32. 32.
    Perry VH, Gordon S (1987) Modulation of CD4 antigen on macrophages and microglia in rat brain. J Exp Med 166:1138–1143Google Scholar
  33. 33.
    Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in adult and developing mouse brain. Neuroscience 15:313–326Google Scholar
  34. 34.
    Phillips JP, Eremin O, Adderson JR (1982) Lymphoreticular cells in human brain tumors and in normal brain. Br J Cancer 45:61–69Google Scholar
  35. 35.
    Piquet V, Diserens AC, Carrel S, March JP, De Tribulet N (1985) The immunohistology of human gliomas. Springer Semin Immunopathol 8:111–127Google Scholar
  36. 36.
    Ridley A, Cavanagh JB (1971) Lymphocytic infiltration in gliomas: evidence of possible host resistence. Brain 94:117–124Google Scholar
  37. 37.
    Robinson AP, White TM, Mason DW (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC Ox-41 and MRC Ox-42, the latter recognizing complement receptor type. Immunology 57:239–247Google Scholar
  38. 38.
    Rossi ML, Cruz-Sanchez F, Hughes J, Esiri MM, Coakham AB, Moss TH (1988) Mononuclear cell infiltrate and HLA-DR expression in low-grade astrocytomas: an immunohistological study of 23 cases. Acta Neuropathol 76:281–286Google Scholar
  39. 39.
    Roszman TL, Brooks WH, Elliott LH (1987) Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor. J Neurosurg 67:874–879Google Scholar
  40. 40.
    Safdari H, Hochberg FH, Richardson EP Jr (1985) Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surg Neurol 23:221–226Google Scholar
  41. 41.
    Schiffer D, Croveri G, Pautasso C (1974) Frequenza e significato degli infiltrati linfo-plasmacellulari nei gliom umani. Tumori 60:177–184Google Scholar
  42. 42.
    Selmay KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339–346Google Scholar
  43. 43.
    Simmons D, Seed B (1988) The Fc receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 333:568Google Scholar
  44. 44.
    Stavrou D, Anzil AP, Weidenbach W, Rodt H (1977) Immunofluorescence study of lymphocytic infiltration in gliomas. Identification of T lymphocytes. J Neurol Sci 33:275–282Google Scholar
  45. 45.
    Stevens A, Klöter I, Roggendorf W (1988) Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 61:738–743Google Scholar
  46. 46.
    Streit W, Kreutzberg G (1988) Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248–263Google Scholar
  47. 47.
    Streit W, Graeber M, Kreutzberg G (1989) Expression of Ia antigen on perivascular and micriglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105:115–126Google Scholar
  48. 48.
    Takeuchi J, Barnard RO (1976) Perivascular lymphocytic cuffing in astrocytomas. Acta Neuropathol (Berl) 35:265–271Google Scholar
  49. 49.
    Todd RF, Nadler LM, Schlossman SF (1981) Antigens on human monocytes identified by monoclonal antibodies. J Immunol 126:1435–1442Google Scholar
  50. 50.
    Vass K, Berger ML, Nowak TS, Welch WJ, Lassmann H (1989) Induction of stress protein hsp 70 in nerve cells after status epilepticus in the rat. Neurosci Lett 100:259–264Google Scholar
  51. 51.
    Von Hahnwehr RJ, Hofman FM, Taylor CR, Apuzzo MLJ (1984) Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg 60:1138–1147Google Scholar
  52. 52.
    Westland K, Pollard JD (1988) Proteinase-induced demyelination. An electrophysiological and histological study. J Neurol Sci 82:41–54Google Scholar
  53. 53.
    Wood GW, Moranz RA (1979) Immunohistological evaluation of the lymphoreticular infiltrate in human central nervous system tumors. JNCI 62:485–491Google Scholar
  54. 54.
    Yasuda K, Alderson T, Phillips J, Sikora K (1983) Detection of lymphocytes in malignant gliomas by monoclonal antibodies. J Neurol Neurosurg Psychiatry 46:734–737Google Scholar
  55. 55.
    Yoshimura T, Robinson EA, Tanaka S, Apella E, Kuratsu J, Leonard EJ (1989) Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 169:1449–1460Google Scholar
  56. 56.
    Zwadlo G, Bröcker EB, Bassewitz DB, Feige U, Sorg C (1985) A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134:1487–1492Google Scholar
  57. 57.
    Zwadlo G, Schlegel R, Sorg C (1986) A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and infammatory tissue. J Immunol 137:512–518Google Scholar
  58. 58.
    Zwadlo G, Vögeli R, Schulze-Osthoff K, Sorg C (1987) Monoclonal antibodies to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55:295–301Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • T. Morimura
    • 1
  • C. Neuchrist
    • 1
  • K. Kitz
    • 2
  • H. Budka
    • 1
  • O. Scheiner
    • 3
  • D. Kraft
    • 3
  • H. Lassmann
    • 1
    • 4
  1. 1.Neurologisches InstitutUniversität WienWienAustria
  2. 2.Neurochirurgische KlinikUniversität WienWienAustria
  3. 3.Institut für allgemeine und experimentelle PathologieUniversität WienWienAustria
  4. 4.Institut für HirnforschungÖsterreichische Akademie der WissenschaftenAustria

Personalised recommendations